Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.

Antimicrob Agents Chemother

Unité de Parasitologie, Institut de Médecine Tropicale du Service de Santé des Armées, Boulevard Charles Livon, Parc le Pharo, BP 46, 13998 Marseille Armées, France.

Published: July 2004

The ability of four 9,10-dihydroethanoanthracene derivatives (BG920, BG932, BG958, and BG996), as well as verapamil and promethazine, to reverse chloroquine resistance was assessed against 24 chloroquine-resistant and 10 chloroquine-susceptible strains of Plasmodium falciparum from different countries. The 9,10-dihydroethanoanthracene derivatives clearly increase chloroquine susceptibility only in chloroquine-resistant isolates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC434228PMC
http://dx.doi.org/10.1128/AAC.48.7.2753-2756.2004DOI Listing

Publication Analysis

Top Keywords

chloroquine resistance
8
910-dihydroethanoanthracene derivatives
8
dihydroethanoanthracene derivatives
4
derivatives vitro
4
vitro malarial
4
malarial chloroquine
4
resistance reversal
4
reversal agents
4
agents ability
4
ability 910-dihydroethanoanthracene
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!